Literature DB >> 22849322

Low number of memory B cells in the salivary glands of patients with primary Sjögren's syndrome.

Lara A Aqrawi1, Karl A Brokstad, Kjerstin Jakobsen, Roland Jonsson, Kathrine Skarstein.   

Abstract

We have previously shown that patients with primary Sjögren's Syndrome (pSS) show a significant reduction of autoantigen specific CD27(+) memory B cells and an abnormally elevated level of autoantibody producing plasma cells in peripheral blood (PB) compared to controls. Because both memory B cells and plasma cells have been detected in salivary glands (SG) of pSS patients, we aimed to study the B cell pattern in SG biopsies. Double immunohistochemical staining of CD20 and CD27 was carried out on paraffin-embedded SG tissue from 10 pSS patients to distinguish CD20(+)/CD27(+) memory B cells, and identify the CD20(+) glandular B cell zones (BCZ). Given that plasma blasts and plasma cells are CD27(++) and CD20(- ), additional CD138 single staining of serial sections allowed the distinction of CD27(++)/CD138(- ) plasma blasts located within the BCZ from CD27(++)/CD138(+) plasma cells that were found mostly on the periphery of the BCZ and also observed interstitially. Both BCZ and the memory B cell populations were then quantified. Contrary to what has been reported earlier through immunoflourescent staining of memory B cells in SG tissue, we have shown that there is a low number of memory B cells located within the glandular BCZ. Plasma blasts and plasma cells, however, were more abundant in the SG. Together our findings suggest that these low numbers of memory B cells in both PB and SG of pSS patients may be the result of activation of these cells into plasma cells at the site of inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22849322     DOI: 10.3109/08916934.2012.712170

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  8 in total

Review 1.  Contributions of Major Cell Populations to Sjögren's Syndrome.

Authors:  Richard Witas; Shivai Gupta; Cuong Q Nguyen
Journal:  J Clin Med       Date:  2020-09-22       Impact factor: 4.241

2.  Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.

Authors:  L A Aqrawi; K Skarstein; G Øijordsbakken; K A Brokstad
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

Review 3.  Autoimmunity in 2012.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 4.  Polychromatic flow cytometry in evaluating rheumatic disease patients.

Authors:  Chungwen Wei; Scott Jenks; Iñaki Sanz
Journal:  Arthritis Res Ther       Date:  2015-03-05       Impact factor: 5.156

5.  Acquisition of N-Glycosylation Sites in Immunoglobulin Heavy Chain Genes During Local Expansion in Parotid Salivary Glands of Primary Sjögren Patients.

Authors:  Annie Visser; Marieke E Doorenspleet; Niek de Vries; Fred K L Spijkervet; Arjan Vissink; Richard J Bende; Hendrika Bootsma; Frans G M Kroese; Nicolaas A Bos
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

Review 6.  Current concepts on Sjögren's syndrome - classification criteria and biomarkers.

Authors:  Roland Jonsson; Karl A Brokstad; Malin V Jonsson; Nicolas Delaleu; Kathrine Skarstein
Journal:  Eur J Oral Sci       Date:  2018-10       Impact factor: 2.612

7.  Elevated cytokine levels in tears and saliva of patients with primary Sjögren's syndrome correlate with clinical ocular and oral manifestations.

Authors:  Xiangjun Chen; Lara A Aqrawi; Tor Paaske Utheim; Behzod Tashbayev; Øygunn Aass Utheim; Sjur Reppe; Lene Hystad Hove; Bente Brokstad Herlofson; Preet Bano Singh; Øyvind Palm; Hilde Kanli Galtung; Janicke Cecilie Liaaen Jensen
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

Review 8.  B cell dysregulation in primary Sjögren's syndrome: A review.

Authors:  Hazim Mahmoud Ibrahem
Journal:  Jpn Dent Sci Rev       Date:  2019-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.